Found: 107
Select item for more details and to access through your institution.
Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 11, p. 3919, doi. 10.1172/JCI63888
- By:
- Publication type:
- Article
Left ventricle function and post-transcriptional events with exercise training in pigs.
- Published in:
- PLoS ONE, 2024, v. 18, n. 2, p. 1, doi. 10.1371/journal.pone.0292243
- By:
- Publication type:
- Article
Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Hemodynamic Determinants of Echocardiographically-Derived Indices of Left Ventricular Filling.
- Published in:
- Echocardiography, 1992, v. 9, n. 3, p. 289, doi. 10.1111/j.1540-8175.1992.tb00472.x
- By:
- Publication type:
- Article
β3 Integrin in Cardiac Fibroblast Is Critical for Extracellular Matrix Accumulation during Pressure Overload Hypertrophy in Mouse.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0045076
- By:
- Publication type:
- Article
Stroke in patients with heart failure and reduced or preserved ejection fraction.
- Published in:
- European Heart Journal, 2023, v. 44, n. 31, p. 2998, doi. 10.1093/eurheartj/ehad338
- By:
- Publication type:
- Article
Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 24, p. 2202, doi. 10.1093/eurheartj/ehad210
- By:
- Publication type:
- Article
Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox.
- Published in:
- European Heart Journal, 2023, v. 44, n. 13, p. 1136, doi. 10.1093/eurheartj/ehad083
- By:
- Publication type:
- Article
Investigator-reported ventricular arrhythmias and mortality in heart failure with mildly reduced or preserved ejection fraction.
- Published in:
- European Heart Journal, 2023, v. 44, n. 8, p. 668, doi. 10.1093/eurheartj/ehac801
- By:
- Publication type:
- Article
Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation.
- Published in:
- European Heart Journal, 2022, v. 43, n. 42, p. 4469, doi. 10.1093/eurheartj/ehac487
- By:
- Publication type:
- Article
GUIDE-HF trial of pulmonary artery pressure monitoring in heart failure: impact of the COVID-19 pandemic.
- Published in:
- European Heart Journal, 2022, v. 43, n. 27, p. 2603, doi. 10.1093/eurheartj/ehac114
- By:
- Publication type:
- Article
Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.
- Published in:
- European Heart Journal, 2021, v. 42, n. 36, p. 3741, doi. 10.1093/eurheartj/ehab499
- By:
- Publication type:
- Article
Left ventricular layer function in hypertension assessed by myocardial strain rate using novel one-beat real-time three-dimensional speckle tracking echocardiography with high volume rates.
- Published in:
- Hypertension Research, 2015, v. 38, n. 8, p. 551, doi. 10.1038/hr.2015.47
- By:
- Publication type:
- Article
426 A Beat Away from Precision Medicine: Characterizing Human Cardiac Fibroblast Responsiveness to Hemodynamic Unloading in Heart Failure with Reduced Ejection Fraction.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Relation of N-Terminal Pro-B-Type Natriuretic Peptide With Diastolic Function in Hypertensive Heart Disease.
- Published in:
- American Journal of Hypertension, 2013, v. 26, n. 10, p. 1234, doi. 10.1093/ajh/hpt098
- By:
- Publication type:
- Article
Temporal plasma profiles of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in patients with left ventricular hypertrophy
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse model.
- Published in:
- FASEB Journal, 2016, v. 30, n. 1, p. 370, doi. 10.1096/fj.15-279299
- By:
- Publication type:
- Article
β<sub>3</sub> Integrin-mediated ubiquitination activates survival signaling during myocardial hypertrophy.
- Published in:
- FASEB Journal, 2009, v. 23, n. 8, p. 2759, doi. 10.1096/fj.08-127480
- By:
- Publication type:
- Article
Effects of sacubitril/valsartan according to polypharmacy status in PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 5, p. 1125, doi. 10.1002/ejhf.3223
- By:
- Publication type:
- Article
Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: Long‐term outcomes.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 1051, doi. 10.1002/ejhf.3232
- By:
- Publication type:
- Article
Interatrial shunt therapy in advanced heart failure: Outcomes from the open‐label cohort of the RELIEVE‐HF trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 1078, doi. 10.1002/ejhf.3215
- By:
- Publication type:
- Article
Clinical implications of subclinical left ventricular dysfunction in heart failure with preserved ejection fraction: The PARAGON‐HF study.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 871, doi. 10.1002/ejhf.3167
- By:
- Publication type:
- Article
Independent prognostic importance of blood urea nitrogen to creatinine ratio in heart failure.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 2, p. 245, doi. 10.1002/ejhf.3114
- By:
- Publication type:
- Article
Calcium channel blocker use and outcomes in patients with heart failure and mildly reduced and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 12, p. 2202, doi. 10.1002/ejhf.3044
- By:
- Publication type:
- Article
Knowledge about self‐efficacy and outcomes in patients with heart failure and reduced ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 10, p. 1831, doi. 10.1002/ejhf.2944
- By:
- Publication type:
- Article
Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1606, doi. 10.1002/ejhf.2962
- By:
- Publication type:
- Article
Changes in mid‐regional pro‐adrenomedullin during treatment with sacubitril/valsartan.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1396, doi. 10.1002/ejhf.2957
- By:
- Publication type:
- Article
Incremental prognostic value of biomarkers in PARADIGM‐HF.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1406, doi. 10.1002/ejhf.2887
- By:
- Publication type:
- Article
Clinical characteristics of heart failure with reduced ejection fraction patients with rare pathogenic variants in dilated cardiomyopathy‐associated genes: A subgroup analysis of the PARADIGM‐HF trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1256, doi. 10.1002/ejhf.2886
- By:
- Publication type:
- Article
Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: which comorbidities matter most? An analysis of PARADIGM‐HF and ATMOSPHERE.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 5, p. 687, doi. 10.1002/ejhf.2856
- By:
- Publication type:
- Article
Health‐related quality of life outcomes in PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 12, p. 2264, doi. 10.1002/ejhf.2738
- By:
- Publication type:
- Article
Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta‐analysis of randomized controlled trials.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 9, p. 1665, doi. 10.1002/ejhf.2573
- By:
- Publication type:
- Article
Effect of sacubitril/valsartan on investigator‐reported ventricular arrhythmias in PARADIGM‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 551, doi. 10.1002/ejhf.2419
- By:
- Publication type:
- Article
Influence of study discontinuation during the run‐in period on the estimated efficacy of sacubitril/valsartan in the PARAGON‐HF trial.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 12, p. 2085, doi. 10.1002/ejhf.2262
- By:
- Publication type:
- Article
Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM‐HF trial.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 9, p. 1518, doi. 10.1002/ejhf.2259
- By:
- Publication type:
- Article
Serum potassium and outcomes in heart failure with preserved ejection fraction: a post‐hoc analysis of the PARAGON‐HF trial.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 5, p. 776, doi. 10.1002/ejhf.2134
- By:
- Publication type:
- Article
Prevalence and incidence of intra‐ventricular conduction delays and outcomes in patients with heart failure and reduced ejection fraction: insights from PARADIGM‐HF and ATMOSPHERE.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 12, p. 2370, doi. 10.1002/ejhf.1972
- By:
- Publication type:
- Article
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Serum potassium in the PARADIGM‐HF trial.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2056, doi. 10.1002/ejhf.1987
- By:
- Publication type:
- Article
Serum uric acid, influence of sacubitril–valsartan, and cardiovascular outcomes in heart failure with preserved ejection fraction: PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2020, v. 22, n. 11, p. 2093, doi. 10.1002/ejhf.1984
- By:
- Publication type:
- Article
Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fraction.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Heart failure with preserved ejection fraction in Asia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction.
- Published in:
- 2017
- By:
- Publication type:
- journal article